Fate Therapeutics, Inc.
ENHANCED STEM CELL COMPOSITION
Last updated:
Abstract:
The invention provides improved methods for cell therapy. In particular, the invention provides therapeutic compositions of enhanced hematopoietic stem and progenitor cells having improved engraftment and homing properties, and methods of making the therapeutic compositions. The invention further provides methods of improving the efficacy of hematopoietic stem and progenitor cell transplantation including transplanting the therapeutic composition to subjects in need of hematopoietic system reconstitution.
Status:
Application
Type:
Utility
Filling date:
4 Jun 2021
Issue date:
21 Apr 2022